Journals / Gülhane Tıp Dergisi / 2021 / Cilt: 63 - Sayı: 1

A study of pericardial effusion in HIV positive patients and its correlation with the CD4 count

Pages
20–24
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Twenty-one patients (53.85%) were in the subgroup of CD4 count

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Cardiovascular diseases in human immunodeficiency virus (HIV)-positive patients are becoming increasingly detected in developing countries and pericardial effusion is one of the common problems amongst them.
📊
Key Findings & Data:The relation of CD4 count is also important, as it correlates with the severity of cardiac involvement.
💡
Conclusion & Impact:Twenty-one patients (53.85%) were in the subgroup of CD4 count
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Aims: Cardiovascular diseases in human immunodeficiency virus (HIV)-positive patients are becoming increasingly detected in developing countries and pericardial effusion is one of the common problems amongst them. The relation of CD4 count is also important, as it correlates with the severity of cardiac involvement. The present study was therefore undertaken to determine the clinical profile of pericardial effusion in HIV patients and its correlation with CD4 count. Methods: This cross-sectional study was conducted in a tertiary care hospital from 2015 to 2017 and it included 500 HIV patients, 39 of whom had pericardial effusion. All patients were assessed clinically and had undergone electrocardiograph, echocardiography and CD4 count along with the routine investigations. The presence of pericardial effusion was determined by echocardiography. The pericardial fluid was analyzed for cells, biochemistry, Gram staining, AFB staining and cultures. An attempt was made to correlate the findings with CD4 count. Results: Out of 500 HIV-positive patients, 39 (7.8%) were found to have pericardial effusion. Majority were male (64.1%) and middle-aged (40-65 y/o) (59%). Most of the effusions (61.54%) were quantified as large and the most common etiology was tuberculous (41%). Twenty-one patients (53.85%) were in the subgroup of CD4 count

🔖

Cite This Article

P, S. M., REDDY, C. T., SHASTRY, B. A., SHETTY, G. V., DODDAMANİ, A. (2022). A study of pericardial effusion in HIV positive patients and its correlation with the CD4 count. Gülhane Tıp Dergisi, Cilt: 63 - Sayı: 1, 20–24. https://ajindex.com/articles/526796

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lind A, Reinsch N, Neuhaus K, et al. Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy. Eur J Med Res. 2011;16:480-483
  2. Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection. Mt Sinai J Med. 1998;65:33-39
  3. Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: a global perspective. Eur Heart J. 2013;34:3538-3546
  4. LeWinter M, Kabbani S. Pericardial diseases. In: Zipes DP, Libby P, Bonow RO BE, edd. Braunwald’s Heart Disease. 7th ed. Philadelphia, Pa: Elsevier Saunders; 2005:1757- 1780
  5. Mishra TK, Mishra SK, Singh S. Cardiovascular manifestations of people living with HIV/AIDS: Report from a hot spot in eastern India. Indian Heart J. 2019;71:338-343
  6. Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med. 2009;6:120-127
  7. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J. 2012;33:866-874
  8. Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J. 1999;137:516-521
  9. Eisenberg MJ, Gordon AS, Schiller NB. HIV-associated pericardial effusions. Chest. 1992;102:956-958
  10. Beck CS. Two cardiac compression triads. J Am Med Assoc. 1935;104:714-716
  11. Wagner G, Strauss D. Marriott’s Practical Electrocardiography. 12th ed. Lippincott Williams & Wilkins; 2014:263-267
  12. Nizet PM, Marriott HJ. The electrocardiogram and pericardial effusion. JAMA. 1966;198:169-170
  13. Bruch C, Schmermund A, Dagres N, et al. Changes in QRS voltage in cardiac tamponade and pericardial effusion: reversibility after pericardiocentesis and after anti-inflammatory drug treatment. J Am Coll Cardiol. 2001;38:219-226
  14. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio- Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921- 2964
  15. Ntsekhe M, Mayosi BM. Tuberculo